Company Monitoring Page for Amgen

job ratings (see below graph) for Amgen

latest headlines for company on cafepharma

Amgen, Allergan join Rituxan biosimilar challenge with FDA filing
Pharmaforum
Fri, 12/20/19 - 12:15 pm
Tags:
Amgen, Allergan, biosimilar, Roche, Rituxan
Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning
Xconomy
Thu, 12/12/19 - 11:02 am
Tags:
osteoporosis, Amgen, Europe, romosozumab, Evenity
Amgen rejigs Bay Area presence with deal for new R&D facility
Fierce Biotech
Tue, 12/10/19 - 10:14 am
Tags:
Amgen, Bay Area, San Francisco, R&D
ASH: Amgen's BiTE stalls multiple myeloma relapse in mice in combo with BMS' Revlimid
Fierce Biotech
Mon, 12/9/19 - 09:53 am
Tags:
Amgen, ASH2019, bispecific antibodies, AMG 701, Multiple Myeloma
3 Biotechs Facing FDA Approvals by Year's End
Motley Fool
Mon, 12/9/19 - 09:45 am
Tags:
FDA, Amgen, Vascepa, Allergan, migraines, ubrogepant, Intra-Cellular Therapies, lumateperone, schizophrenia
4 FDA Dates Biotech Investors Should Circle in December
Motley Fool
Sun, 12/8/19 - 10:24 pm
Tags:
FDA, Amgen, anti-inflammatories, ABP710, Bausch Health Companies, acne, IDP-123, Intra-Cellular Therapies, lumateperone, schizophrenia, Vascepa, Amarin
Top 7 Companies in Biotech Beach by Revenue
BioSpace
Thu, 12/5/19 - 10:15 am
Tags:
Biotech Beach, San Diego, California, Amgen, Neurocrine, Acadia Pharmaceuticals, Retrophin, Tocagen, Mirati Therapeutics, AnaptysBio
Amgen snags another Enbrel outcomes-based payment deal as it seeks to prop up aging blockbuster
Fierce Pharma
Wed, 12/4/19 - 11:18 pm
Tags:
Amgen, Enbrel, Abarca, PBMs, rheumatoid arthritis
Amgen juices up sales outlook amid high hopes for Celgene castoff Otezla
Fierce Pharma
Thu, 11/21/19 - 06:29 pm
Tags:
Amgen, Otezla, Celgene, psoriasis
Looking for a Biotech Stock That's an Ideal Buyout Candidate? This Is It.
Motley Fool
Wed, 11/20/19 - 10:02 am
Tags:
Amarin, Vascepa, M&A, Amgen, Novartis, Pfizer
If Biosimilars Are Struggling, Someone Forgot to Tell Coherus BioSciences
Motley Fool
Tue, 11/19/19 - 02:34 pm
Tags:
biosimilars, FDA, Coherus Biosciences, Neulasta, Amgen
Hit by copycat meds, Amgen trims 172 more jobs, this time in operations, R&D and sales
Fierce Pharma
Tue, 11/19/19 - 10:28 am
Tags:
Amgen, layoffs, R&D, drug reps
Top 10 pharma settlements since 2018
Fierce Pharma
Tue, 11/19/19 - 10:27 am
Tags:
settlements, Reckitt Benckiser, JNJ, Bayer, Allergan, Actelion, Purdue Pharma, Teva Pharmaceutical, Endo, Teikoku, Insys, Pfizer, GSK, Astellas, Amgen
AHA: Amgen's Repatha tied to greater risk reduction in high-risk heart attack patients
Fierce Pharma
Mon, 11/18/19 - 10:06 am
Tags:
AHA, Amgen, Repatha, PCSK9 inhibitor, heart attacks
Ahead of FDA decision on BTK drug, Amgen-partnered BeiGene scores China OK for PD-1
Endpoints
Wed, 11/13/19 - 10:03 am
Tags:
China, BeiGene, Amgen, tislelizumab, anti-PD-L1
Amgen to cut 149 staff in retreat from neuroscience R&D
Fierce Biotech
Tue, 11/12/19 - 10:04 am
Tags:
Amgen, Neuroscience, layoffs, R&D
It took a 3-year struggle, but Novartis finally gets a green light on their copycat to Amgen's big blockbuster
Endpoints
Tue, 11/5/19 - 10:23 am
Tags:
Novartis, FDA, Amgen, Neulasta, biosimilars, Ziextenzo, cancer
Biopharma Q3: Pfizer, Merck, Amgen, Incyte and J&J
BioSpace
Sat, 11/2/19 - 07:55 pm
Tags:
earnings, Pfizer, Merck, Amgen, Incyte, JNJ
Amgen pays $2.7bn to harness BeiGene’s China marketing muscle
Pharmaforum
Fri, 11/1/19 - 10:26 am
Tags:
Amgen, China, BeiGene
As Amgen zeroes in on cancer, neuroscience pipeline under the ax
Fierce Biotech
Wed, 10/30/19 - 10:20 am
Tags:
Amgen, KRAS, oncology, cancer, Neuroscience

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.